Web
Site
Search
ABOUT US
TEST MENU
ORDERING
CAREERS
EVENTS
YOUR ACCOUNT
PATIENT HEALTH
Ovatax
New Data Demonstrates Effectiveness of Clarient’s Ovatax™ Test for Ovarian Cancer.
See study, titled “
Expression of TLE3 Predicts Response to Taxane Therapy in Ovarian Carcinoma
,” included 293 carcinoma samples mostly collected at UAB.
Contact Us
|
Trademarks
|
Privacy Policy
|
Terms of Use
|
HIPAA
|
Regulatory & Licensing
Copyright 2012 Clarient, Inc. All Rights Reserved.